These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 6785435

  • 1. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E, Kåss E.
    J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
    [Abstract] [Full Text] [Related]

  • 2. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
    Domljan Z, Borso G, Marinković M, Winter Fudurić I, Pucar I, Cikes N.
    Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
    [No Abstract] [Full Text] [Related]

  • 3. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D, Brook A, Brooks P, Boyden K, Thomas D, Tymms K.
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [Abstract] [Full Text] [Related]

  • 4. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA, Bienz SR, Clegg DO, Ward JR.
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [Abstract] [Full Text] [Related]

  • 5. Gold vs D-penicillamine double blind study and followup.
    Thomas MH, Rothermich NO, Philips VK, Bergen W, Hedrick SW.
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [Abstract] [Full Text] [Related]

  • 6. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A, Anastassiades T.
    Clin Invest Med; 1984 Dec; 7(1):65-71. PubMed ID: 6426836
    [Abstract] [Full Text] [Related]

  • 7. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same?
    Jellum E, Aaseth J, Munthe E.
    Proc R Soc Med; 1977 Dec; 70 Suppl 3(Suppl 3):136-9. PubMed ID: 122761
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O, Smolen JS, Mayr WR, Mayrhofer F, Kolarz G, Thumb NJ.
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [Abstract] [Full Text] [Related]

  • 12. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ.
    N Engl J Med; 1980 Aug 07; 303(6):300-2. PubMed ID: 6770269
    [Abstract] [Full Text] [Related]

  • 13. Near-cytotoxic gold salt therapy in long standing drug-refractory rheumatoid arthritis. A prospective investigation.
    de Bosset PL, Biter T.
    Schweiz Med Wochenschr; 1973 Aug 18; 103(33):1153-8. PubMed ID: 4201618
    [No Abstract] [Full Text] [Related]

  • 14. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
    Dahl SL, Samuelson CO, Williams HJ, Ward JR, Karg M.
    Pharmacotherapy; 1990 Aug 18; 10(2):79-84. PubMed ID: 2112243
    [Abstract] [Full Text] [Related]

  • 15. [HLA antigens and side effects of gold and D-penicillamine in chronic polyarthritis].
    Scherak O, Smolen JS, Mayr WR, Mayrhofer F, Kolarz G, Thumb N.
    Wien Klin Wochenschr Suppl; 1984 Aug 18; 156():51-2. PubMed ID: 6442059
    [No Abstract] [Full Text] [Related]

  • 16. Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial.
    Kvien TK, Høyeraal HM, Sandstad B.
    J Rheumatol; 1985 Jun 18; 12(3):533-9. PubMed ID: 3930720
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Long-term comparative studies on gold, D-penicillamine, and NSAIDs for the treatment of early rheumatoid arthritis. 1. Evaluation of one year's treatment].
    Azuma T, Sugawara S, Maeda A, Miyauchi T, Aritomi H.
    Ryumachi; 1986 Jun 18; 26(3):200-9. PubMed ID: 3097838
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
    Halberg P.
    Ugeskr Laeger; 1984 Jul 02; 146(27):1995-2000. PubMed ID: 6440327
    [No Abstract] [Full Text] [Related]

  • 20. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined?
    Bird HA.
    Br J Rheumatol; 1989 Feb 02; 28(1):39. PubMed ID: 2492869
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.